Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Brain Neoplasms × Ultrasonography × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Prostatic Neoplasms 6 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Tongue Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Liver Cirrhosis 2 Carcinoma, Hepatocellular 2 Urologic Neoplasms 1 Urethral Neoplasms 1 Thoracic Neoplasms 1 Testicular Neoplasms 1 Solid Tumor 1 Renal Colic 1 Rectal Neoplasms 1 Pregnancy, Ectopic 1 Pneumonia 1 Pleural Effusion 1 Phlebitis 1 Penile Neoplasms 1 Mesothelioma 1 Melanoma 1 Margins of Excision 1 Lymphoma, Primary Effusion 1 Lymphoma, B-Cell 1 Lymphoma, AIDS-Related 1 Lung Neoplasms 1

Interventions

Temozolomide 133 Radiosurgery 101 Radiotherapy 83 Bevacizumab 83 Magnetic Resonance Spectroscopy 56 Carboplatin 44 Etoposide 31 pembrolizumab 30 Irinotecan 28 Cyclophosphamide 28 Surgical Procedures, Operative 27 Nivolumab 27 Erlotinib Hydrochloride 26 Radiation 24 Carmustine 24 Lomustine 21 Filgrastim 21 Cisplatin 20 Trastuzumab 19 Ipilimumab 19 Aminolevulinic Acid 18 Vincristine 17 Capecitabine 17 Specimen Handling 16 Pemetrexed 16 Mental Status and Dementia Tests 16 Topotecan 15 Lapatinib 13 Imatinib Mesylate 13 Granulocyte Colony-Stimulating Factor 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02656407 2025-09-02

FUSIMAGINE

Institut National de la Santé Et de la Recherche Médicale, France

Phase NA Completed

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡